Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue
Copenhagen, Denmark, 22 January 2025 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or the “Company”) announces that today, its Board of Directors has decided to carry out a rights issue of units with preferential subscription rights for the Company’s existing shareholders (the “Rights Issue”). The units consist of new Brain+ shares and warrants of series TO 5. The decision to raise new capital is aligned with a comprehensive restructuring initiative to implement a leaner business model, pause new product development and focus all resources on directly revenue-driving